À/ À ) have a higher blood pressure (BP) and higher reactive oxygen species (ROS) production than their D 5 R wild-type littermates (D 5 þ / þ ). We tested the hypothesis that the high BP and increased ROS production in D 5 À/ À mice may be caused by decreased heme oxygenase-1 (HO-1) expression and activity. We found that renal HO-1 protein expression and HO enzyme activity were decreased (65 and 50%, respectively) in 
INTRODUCTION
The peripheral dopaminergic system regulates renal function, sodium balance and blood pressure (BP) through its actions on renal hemodynamics, epithelial ion transport, and humoral/hormonal agents. [1] [2] [3] Dopamine exerts its actions via two families of cell surface receptors that belong to the superfamily of G proteincoupled receptors. These include D 1 -like (D 1 R and D 5 R) and D 2 -like receptors (D 2 R, D 3 R, and D 4 R) in mammals. [4] [5] [6] There is abundant evidence that an intact dopaminergic system is necessary to maintain normal BP, and that genetic hypertension is associated with alterations in dopamine production and receptor function. [4] [5] [6] The disruption of any of the dopamine receptor genes in mice produces dopamine receptor subtype-specific hypertension. [6] [7] [8] [9] The loci of the human D 5 dopamine receptor (D 5 R) and its pseudogenes have been linked to human essential hypertension. 10, 11 Disruption of the D 5 receptor gene (Drd5) in mice (D 5 À/ À ) causes hypertension. 12 Reactive oxygen species (ROS) are ubiquitous, highly diffusible reactive molecules produced by reduction of molecular oxygen, and include a series of oxygen intermediates, such as the superoxide anion, hydrogen peroxide, hydroxyl radical and hypochlorous acid. [13] [14] [15] There are several intracellular sources contributing to ROS generation, including mitochondrial respiration, cyclooxygenases, lipoxygenases, and NADPH oxidases, the major source of superoxide anion in vascular and renal tissues. 16 Increased production of ROS has been reported in human essential hypertension, as well as in animal models of genetic and acquired hypertension. 13, [17] [18] [19] [20] [21] Increased levels of ROS are caused not only by enhanced oxidant activity, but also by deficient activity of antioxidant enzymes, for example, heme oxygenase (HO). [22] [23] [24] [25] [26] HO catalyzes the degradation of heme, resulting in the formation of iron, carbon monoxide (CO), and biliverdin, which is subsequently converted to bilirubin by biliverdin reductase. 22, 23 Three HO isoforms have been reported: an inducible isoform, HO-1; and two constitutively expressed isoforms, HO-2 and HO-3. 22, 23 HO-1 is highly inducible in response to various stimuli that are associated with oxidative stress and inflammation, including heme, hypoxia, ischemia, heavy metals, ultraviolet radiation, endotoxin, and proinflammatory cytokines. 24, 25 A lack of HO is involved in the pathogenesis of hypertension associated with increased ROS, 23, 24, 27, 28 and induction of HO inhibits NADPH oxidase activity and decreases ROS production. [29] [30] [31] We have reported that D 5 À/ À mice are hypertensive, in part, because of increased systemic production of ROS through increased expression and activity of NADPH oxidase. 13 In the current study, we tested the hypothesis that the D 5 R inhibits ROS production, not only by inhibiting NADPH oxidase expression and activity, but also by increasing HO-1 expression and activity.
METHODS

D 5
À/ À Mice
The generation of D 5 À/ À mice has been reported. 12, 13, 17 In this study, adult (6-month old) sex-matched sixth generation progeny (F 6 , C57/BL/6 Taconic) D 5 À/ À and D 5 R wild-type (D 5 þ / þ ) littermates fed with a normal sodium diet were used. Six-month old mice were studied to make them comparable with our previous reports. 12, 13, 17 Our protocol was approved by the Georgetown University Animal Care and Use Committee. The BPs were measured from the femoral artery of avertin-anesthetized mice. The BPs were recorded 1 h after the induction of anesthesia and when the BPs were stable. An intraperitoneal injection of hemin (50 mmol kg À1 ), an HO-1 inducer, was given. 23 Then, the femoral artery was repaired and the skin sutured. The mice were injected intramuscularly with Buprenorphine (0.3 mg kg À1 ) and allowed to recover. Twenty-four hours later, the mice were again anesthetized with avertin and BP was measured using the other femoral artery. At the end of the experiment, the kidneys were harvested and stored at À70 1C until use; the mice were euthanized with an overdose of pentobarbital.
Cell culture, treatment and transfection HEK-293 cells, stably expressing full-length human D 5 R (hD 5 R) tagged withV 5 /HIS (HEK-hD 5 R) (passage 2-6), or empty vector-transfected HEK-293 (HEK-vector) cells were cultured in DMEM (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum, 100 mg ml À1 streptomycin and 100 Uml À1 penicillin at 37 1C in an incubator with a humidified atmosphere of 95% air and 5% CO 2 , as reported. 13, 17 Cells were pretreated for 2 h with serum-free medium and then treated with 1 mM fenoldopam (Fen) at different time points (0-24 h). Fen is selective for both D 1 R and D 5 R, but is specific for D 5 R in HEK-hD 5 R because D 1 R is not expressed. 13, 17 Stable transfection of hD 5 HO-1 gene silencing with siRNA HEK-hD 5 R (30-50% confluence) cells were split into 6-well plates the day before the transfection. Twenty microlitres of 10 mmol l À1 human HO-1 siRNA, 31 diluted with 180 ml of Opti-Mem I, were mixed with 5 ml oligofectamine transfection reagent (Invitrogen). The mixture was incubated at room temperature for 20 min to form liposome-siRNA complexes prior to transfection of the cells (10 nM, 24 h).
Measurement of HO activity
Microsomal HO activity was assessed by bilirubin formation in the presence of purified biliverdin reductase. 32 The amount of bilirubin formed was calculated using an extinction coefficient of 40 mmol l À1 cm À1 at a wavelength from 465 to 530 nm. HO activity was expressed as nanomol of bilirubin formed per milligram of protein per hour (nmol bilirubin per mg protein per h).
Immunoblotting analysis
Kidney homogenates or cell lysates were used to measure HO-1, HO-2 and b-actin expressions by immunoblotting with monoclonal anti-HO-1, anti-HO-2 (Stressgen Biotechnologies; British Columbia, Canada) and anti-b-actin antibodies (Millipore, Billerica, MA, USA). The membrane was washed three times with TBS-T buffer and subsequently probed with a secondary horseradish peroxidase-conjugated goat anti-mouse antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Chemiluminescence was detected using an ECL detection kit (Pierce Biotechnology Inc., Rockford, IL, USA), followed by autoradiography. Protein loading and membrane transfer were determined by immunoblotting for b-actin.
Immunoprecipitation
Immunoprecipitation was performed as described. 33 Equal amounts of lysate protein of HEK-hD 5 R cells treated with Fen (1 mmol l À1 , 3 and 12 h) were incubated with 2 mg ml À1 of anti-V 5 antibody (Santa Cruz Biotechnology) for 1 h and protein-G agarose at 4 1C overnight. The immunoprecipitate was pelleted, washed four times with PBS, resuspended in sample buffer, boiled and immunoblotted with the HO-1 antibody. To determine the specificity of the bands, normal mouse IgG (negative control) and HO-1 antibody (positive control) were used as immunoprecipitants in lieu of the V 5 antibody.
Immunofluorescence microscopy HEK-hD 5 R cells treated with vehicle or Fen (1 mmol l À1 , 3 and 12 h) were used for immunofluorescence. The D 5 R was immunostained with monoclonal anti-V5 antibody and HO-1 with monoclonal anti-HO-1 antibody. For a negative control, the primary antibodies were replaced with normal mouse serum at an appropriate dilution. Colocalization of the D 5 R and HO-1 was identified by the appearance of a yellow color in the merged images.
Real-Time quantitative PCR
Total RNA extracted from mouse kidney or HEK-hD 5 R cells with RNeasy Mini Kit (Qiagen, Valencia, CA, USA) was reverse transcribed using M-MLV reverse transcriptase (Invitrogen). Two microlitres of the cDNA were used for realtime PCR (SYBR Green qPCR Supermix UDG Kit, Invitrogen): 50 1C for 2 min and 95 1C for 10 min, followed by 40 cycles at 95 1C for 15 s and 63 1C for 60 s. Real-time PCR reactions were carried out in a total volume of 25 ml using predesigned QuantiTect Primers for HO-1 and b-actin (Qiagen). All measurements were performed in triplicate to ensure reproducibility. The ratio of mean ± s.e. of the expression of HO-1 to b-actin was calculated for sample-tosample comparison.
NADPH oxidase assay and ROS production NADPH oxidase activity was determined by NADPH-induced chemiluminescence in the presence of lucigenin (5 mmol l À1 ) and NADPH (100 mmol l À1 ). 13 The specificity of the NADPH-dependent superoxide anion production was verified by treatment with diphenylene iodonium. NADPH oxidase activity was expressed as arbitrary units corrected by the protein concentration (AU per mg protein). ROS production in renal homogenates was quantified using the superoxide dismutase-inhibitable cytochrome c reduction assay. 13 
Statistical analysis
Data are expressed as mean ± s.e. Comparison among and within groups of more than two was made by factorial and repeated-measures ANOVA and Newman-Keuls (multiple comparisons), respectively, and Student's t-test was used for the comparison between two groups. A value of Po0.05 was considered statistically significant.
RESULTS
In vivo studies
Blood pressure and heart rate in D 5 À/ À mice. Pentobarbitalanesthetized D 5 À/ À mice had higher systolic BP (123 ± 1 vs. 96 ± 1 mm Hg, Po0.01), diastolic BP(89 ± 2 vs. 69 ± 2 mm Hg, Po0.01) and mean arterial BP(100±2 vs. 78±1 mm Hg, Po0.01) than their D 5 þ / þ littermates. The high BP of D 5 À/ À mice was normalized 24 h after the administration of hemin, whereas the BP of D 5 þ / þ littermates was not affected by hemin (Figures 1a,b and c). The heart rates were similar in pentobarbital-anesthetized D 5 þ / þ and D 5 À/ À mice before and after hemin treatment (Figure 1d ).
ROS production in D 5
À/ À mice. Renal ROS production was increased by 1.8- 
2; pmol per mg protein per min, Po0.05). The increased renal ROS production in D 5 À/ À mice was almost completely abolished by hemin treatment (Figure 1e ).
HO-1 expression in D 5
À/ À mice. The renal protein expression of HO-1 was decreased by 65% in D 5 À Figure S1A) . We next determined if the increased HO-1 expression caused by hemin was due to increased gene transcription. We found that renal HO-1 mRNA expression (realtime QRT-PCR) was similar in D 5 À/ À mice and D 5 þ / þ littermates in the basal state; hemin treatment increased HO-1 mRNA expression to a similar extent in D 5 þ / þ (hemin: 270 ± 50%; vehicle: 100 ± 3%, Po0.05) and D 5 À/ À mice (hemin: 300 ± 48%; vehicle: 98 ± 5%, Po0.05) (Figure 2b ). These data indicate that the cause of the differential HO-1 protein expression between the two mouse strains is at the post-transcriptional level.
HO enzyme activity in D 5
À/ À mice. Microsomal HO activity was decreased by 50% in the kidneys of D 5 In vitro studies HO-1 protein expression and HO activity in HEK-hD 5 R cells. To evaluate directly the role of D 5 R in the regulation of HO-1 expression and activity, studies were performed in HEK-293 cells, which do not endogenously express D 1 R or D 5 R but were generated to express heterologously the human wild-type D 5 R (HEK-hD 5 R). 13, 17 Expression of HO-1 protein was increased by 2.3-fold in HEK-hD 5 R cells relative to HEK-vector cells (n ¼ 3, Po0.01) (Figure 3a) . Fen treatment increased HO-1 expression in a time-and concentrationdependent manner (Figures 3b and c (Figure 3e ) and decreased thereafter, but remained at least twice the basal levels at 24 h.
Colocalization and co-immunoprecipitation of hD 5 R and HO-1 in HEK-hD 5 R cells. To determine the mechanism for the increased HO-1 activity (from 3 h) prior to the increase in HO-1 protein expression (from 12 h) by D 5 R, we next determined if D 5 R and HO-1 could directly interact with each other in HEK-hD 5 R cells by colocalization and co-immunoprecipitation studies. Using confocal immunofluorescence microscopy, we found that in vehicle-treated cells, the D 5 R was mainly located at the plasma membrane, whereas HO-1 was primarily located in the cytosol; there was some colocalization between D 5 R and HO-1 in either plasma membrane or cytosol (Figure 4a ). Fen treatment (1 mmol l À1 , 3 h) promoted D 5 R internalization and, along with HO-1, redistribution to the perinuclear area where they colocalized. Colocalization was also observed at the plasma membrane (Figure 4a) . Colocalization continued to be observed after 12 h of treatment. There was physical interaction between D 5 R and HO-1 because co-immunoprecipitation was increased at 3 h of Fen (1 mmol l À1 ) treatment, and decreased after 12 h of treatment (Figure 4b ), similar to that observed with HO activity (Figure 3e ). To prove that HO-1 mediates, in part, the antioxidative effect of D 5 R, we studied the consequence of silencing HO-1 gene expression on the inhibitory effect of D 5 R on NADPH oxidase. As expected, 24 h after HO-1 siRNA transfection, mRNA and protein expressions of HO-1 were significantly decreased (70 and 76%, respectively) ( Supplementary Figures S1C and S1D) . HO activity was decreased to same level in HEK-vector cells (non-silencing siRNA: 0.017±0.001; HO-1 siRNA: 0.011 ± 0.001, nmol bilirubin per mg protein per h, Po0.05) and HEK-hD 5 R cells (non-silencing siRNA: 0.023 ± 0.001; HO-1 siRNA: 0.012±0.001, nmol bilirubin per mg protein per h, Po0.05) (Figure 5b) , corroborating the results shown in Figures 3e  and 5a regarding the constitutive activity of D 5 R and increased HO activity. As shown in Figure 5c , silencing HO-1, alone increased the NADPH oxidase activity by 1.6-fold in HEK-vector cells (nonsilencing siRNA: 1074 ± 83; HO-1 siRNA: 1602 ± 106, AU per mg protein, Po0.05) and completed abolished the inhibitory effect of D 5 R on basal NADPH oxidase activity in HEK-hD 5 R cells, that is, NADPH oxidase activity was not constitutively decreased by D 5 R when HO-1 was silenced.
In HEK-hD 5 R cells, Fen (1 mmol l À1 , 12 h) treatment decreased NADPH oxidase activity by 72% in non-silencing siRNA-transfected cells (vehicle: 3166 ± 193; Fen: 886 ± 92, AU per mg protein, Po0.01) (Figure 5d ). In contrast, in HO-1 siRNA-transfected HEK-hD 5 R cells, the ability of Fen to decrease NADPH oxidase activity was reduced by about 50% (Fen þ HO-1 siRNA: 2216±120, AU per mg protein, Po0.01) (Figure 5d ), indicating that HO-1 mediated, in part, the ability of D 5 R to attenuate NADPH oxidase.
DISCUSSION
Oxidative stress is increased in both humans with essential hypertension and several animal models of hypertension. 13, [16] [17] [18] [19] [20] 24, [26] [27] [28] 34 We have reported that the increased BP in D 5 À/ À mice is, in part, due to an increase in oxidative stress as a consequence of the activation of NADPH oxidase. 13 The D 5 R constitutively inhibits the expression and activity of the pro-oxidant enzyme NADPH oxidase. 13 We now show that the increase in oxidative stress and BP in R results in an increase in ROS production due to both an increase in NADPH oxidase subunit expression (gp91phox, p47phox and Nox 4) and activity, 13 and a decrease in HO-1 protein and activity (current study). Thus, in this study, we demonstrate for the first time, that renal HO-1 is positively regulated by D 5 R in vivo and in vitro, and that HO-1 negatively regulates NADPH oxidase activity via the D 5 R.
The levels of HO-1 mRNA are increased after 24 h treatment with hemin in both D 5 À/ À and D 5 þ / þ mice. However, whereas hemin does not affect HO-1 protein levels and activity in the wild-type (D 5 þ / þ ) littermates, it increases HO-1 protein levels and normalizes HO-1 activity in D 5 À/ À mice. The regulation of HO-1 expression is not only dependent on transcription but also on translation, 35 and it is possible that the increased oxidative stress in the kidneys of D 5 À/ À mice may have made them more sensitive to HO-1 protein induction than their wild-type counterparts.
In HEK-hD 5 R cells, D 5 R stimulation with Fen increases HO activity much earlier (3 h) (Figure 3e ) than its ability to increase HO-1 protein expression (12 h) (Figure 3b) . The D 5 R-mediated increase in HO-1 activity before there is an increase in HO-1 protein may be due to a direct effect of D 5 R on HO-1, because the colocalization and physical interaction between D 5 R and HO-1 are increased by Fen at 3 h when HO activity is also increased. These results suggest that the early increase in HO-1 activity after Fen treatment (3 h) may be due to protein-protein interaction, whereas the later increase (12 h) may be via increased protein expression.
Dopamine has been reported to increase HO-1 expression in neuronal and endothelial cells. 36, 37 Fen has also been shown to increase HO-1 protein expression that may protect renal proximal tubule cells and kidneys from cold-ischemia and reperfusion injury. 38 Our studies suggest that the dopamine receptor subtype involved is probably D 5 R. The mechanism by which D 5 R upregulates HO-1 protein expression is still unknown. Apomorphine, a dopamine agonist that activates both D 1 -like and D 2 -like receptors, stimulates the nuclear translocation of a basic leucine zipper transcription factor, nuclear factor-E2-related factor-2, increases the expression of HO-1 and prevents neuronal death. 39 The antioxidant effect of D 1 -like receptor in human renal proximal tubule cells may also be modified by nuclear factor-E2-related factor-2. 40 The Nrf2/HO-1 pathway can be regulated by the PI3K-Akt pathway, [41] [42] [43] and D 5 R activation, via PI3K-Akt pathway, increases the phosphorylation of Akt 44 in neurons. Thus, we propose that the activation of the PI3K-Akt pathway by D 5 R is involved in its ability to induce HO-1 protein expression.
In conclusion, we suggest that renal HO-1 is positively regulated by D 5 R and mediates, in part, the inhibitory effect of renal D 5 R on NADPH oxidase activity. D 5 R positively regulates HO-1 activity through direct protein-protein interaction in the short-term and via increasing HO-1 protein expression in the long-term. D 5 R, via HO-1, counter-regulates renal ROS production, thereby contributing to the maintenance of normal BP. 45 
